Industry Symposium Supported by GSK: Current Issues in Multiple Myeloma: Management of the Aging Population

Chair(s)

• 

  Paul Richardson, MD

  Clinical Program Leader and Director of Clinical Research
  Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
  Boston, Massachusetts, United States

Presentations:

• 11:45 AM – 11:55 AM EEST

  Increasing heterogeneity of the aging MM patient population: diagnostic challenges
  

  Speaker: Alessandra Larocca, MD, PhD – University of Torino
• 11:55 AM – 12:05 PM EEST

  Aging of the general population and its impact on MM treatment
  

  Speaker: Yael C. Cohen, MD – Tel- Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
• 12:05 PM – 12:15 PM EEST

  Treatment options for elderly patients in early RRMM: immunomodulatory agents, proteasome inhibitors, anti-CD38 antibodies, and more
  

  Speaker: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
• 12:15 PM – 12:25 PM EEST

  BCMA-targeted treatment options for elderly patients in early RRMM
  

  Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia
• 12:25 PM – 12:35 PM EEST

  Roundtable discussion: Practical considerations (eligibility, access, and benefit/risk)
• 12:35 PM – 12:42 PM EEST

  Audience Q&A
• 12:42 PM – 12:45 PM EEST

  Closing Remarks